Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways
21 May 2026 at 08:00
Oncogenesis, Published online: 21 May 2026; doi:10.1038/s41389-026-00628-y
Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways